BDBM593264 (1R,4R)-4-(((2-((5-chloro-1- (tetrahydro-2H-pyran-4-yl)-1H- pyrazol-4-yl)amino)-5- fluoropyrimidin-4- yl)oxy)methyl)cyclohexan-1-ol::US11578061, Example 242
SMILES O[C@H]1CC[C@H](COc2nc(Nc3cnn(C4CCOCC4)c3Cl)ncc2F)CC1
InChI Key InChIKey=QSCGSDIIMZGVDD-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 593264
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [970-2527](Human)
Halia Therapeutics
US Patent
Halia Therapeutics
US Patent
Affinity DataIC50: 50nMAssay Description:LRRKtide substrate (peptide sequence RLGRDKYKTLRQIRQ, derived from human ezrin [amino acids 561-573], moesin [amino acids 539-553] and radixin [amino...More data for this Ligand-Target Pair
